Life Sciences Brazil Global Guide 2025 | Chambers & Partners

We are pleased to announce our collaboration on the Chambers and Partners Life Sciences 2025 Global Practice Guide!

Our partners Priscila Kashiwabara and Viviane Trojan, along with attorneys Gustavo Vicenti and Giovanna Verginelli Mezher, authored the Life Sciences 2025 guide for Brazil. This guide outlines the regulatory framework for pharmaceuticals and medical devices, detailing legislation, regulatory bodies, and procedures for approvals and appeals. It covers categorization, clinical trials, marketing authorizations, and ongoing obligations.

The guide also emphasizes ANVISA’s role in regulation, stringent requirements for biologics, and procedures for compassionate use and post-marketing surveillance. Additionally, it addresses manufacturing authorizations, distribution regulations, and measures against counterfeit products.

Click here to read the full article: https://lnkd.in/dbU5yrvD.